This chart says SKTO climbed to .06 on more or less nothing. That was before Berkeley Bio (Gold Standard of Game-Changing Medical Cannabis Products), and before the ground-breaking Dharmanol was ready to be shipped, and before the T-Hydrocan line was next up with other products in pipeline, and before Dharmanol was seen as supplanting"Valium" and "Xanax," and before "over 400 collectives" were participating with MG, and before numerous CA growers were recruited to fill demand for MG/BB products, and before a 20-state count legalizing MMJ, and before CO and WT legalized recreational MJ, and before feds backed off medical cannabis, and before recent news of 12,000 sq ft. indoor grow facility exclusively dedicated to filling demand for MG/BB products, and before reports from beta testers praising Dharmanol's health-infusing and becalming effects. Therefore, at 0.02 with $12m market cap, there's
plenty of room for SKTO to run.